216 related articles for article (PubMed ID: 26228687)
1. Hepatitis C virus infection in Taiwan: Past, present, and future.
Kao JH
J Formos Med Assoc; 2016 Feb; 115(2):65-6. PubMed ID: 26228687
[No Abstract] [Full Text] [Related]
2. [Hepatitis C virus genotype 4: epidemiology and treatment].
Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
[No Abstract] [Full Text] [Related]
3. Novel therapies in Hepatitis C virus. Preface.
Pockros PJ
Clin Liver Dis; 2009 Aug; 13(3):xiii. PubMed ID: 19628152
[No Abstract] [Full Text] [Related]
4. Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure.
Yu ML; Dai CY; Huang JF; Chuang WL
Hepatology; 2008 Sep; 48(3):1019-20; author reply 1020-1. PubMed ID: 18756469
[No Abstract] [Full Text] [Related]
5. Optimal dosage of ribavirin.
Mangia A; Andriulli A
Hepatology; 2010 Sep; 52(3):1174. PubMed ID: 20812365
[No Abstract] [Full Text] [Related]
6. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.
Bruchfeld A; Lindahl K; Stahle L; Schvarcz R
J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023
[No Abstract] [Full Text] [Related]
7. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
8. Hepatitis C virus infection: the new global epidemic.
Butt AA
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):241-9. PubMed ID: 15918781
[TBL] [Abstract][Full Text] [Related]
9. [Genotype 1 superresponder treat for only 24 weeks].
MMW Fortschr Med; 2005 Dec; 147(51-52):69. PubMed ID: 16402717
[No Abstract] [Full Text] [Related]
10. Interferon for hepatitis C patients with psychiatric disorders.
Rifai MA; Bozorg B; Rosenstein DL
Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
[No Abstract] [Full Text] [Related]
11. High rate of infection with hepatitis C virus genotype 4 in a district of galicia, Spain.
Martinez SM; Delgado MB; Castroagudín JF; Aguilera A
J Clin Microbiol; 2005 Oct; 43(10):5403-4. PubMed ID: 16208032
[No Abstract] [Full Text] [Related]
12. [Peginterferon-alfa-2b or -alfa-2a and ribavirin combined treatment in hepatitis C infection].
Szalay F
Orv Hetil; 2010 Feb; 151(7):271-3. PubMed ID: 20133247
[No Abstract] [Full Text] [Related]
13. Optimal therapy in genotype 1 patients.
Farnik H; Mihm U; Zeuzem S
Liver Int; 2009 Jan; 29 Suppl 1():23-30. PubMed ID: 19207963
[TBL] [Abstract][Full Text] [Related]
14. Treatment duration for genotypes 2 and 3: still confusing after all these years.
Jensen DM
J Clin Gastroenterol; 2010 Sep; 44(8):527-8. PubMed ID: 20628314
[No Abstract] [Full Text] [Related]
15. How to optimize current treatment of genotype 2 hepatitis C virus infection.
Marciano S; Gadano AC
Liver Int; 2014 Feb; 34 Suppl 1():13-7. PubMed ID: 24373073
[TBL] [Abstract][Full Text] [Related]
16. Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
Bini EJ; Mehandru S
Aliment Pharmacol Ther; 2006 Mar; 23(6):777-85. PubMed ID: 16556180
[TBL] [Abstract][Full Text] [Related]
17. Therapeutics: new drugs hit the target.
Schlütter J
Nature; 2011 Jun; 474(7350):S5-7. PubMed ID: 21666733
[No Abstract] [Full Text] [Related]
18. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
[TBL] [Abstract][Full Text] [Related]
19. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
Boulestin A; Sandres-Saune K; Alric L; Pipy B; Dubois M; Vinel JP; Izopet J
Antivir Ther; 2005; 10(4):499-504. PubMed ID: 16038475
[TBL] [Abstract][Full Text] [Related]
20. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.
Levine JW; Gota C; Fessler BJ; Calabrese LH; Cooper SM
J Rheumatol; 2005 Jun; 32(6):1164-7. PubMed ID: 15940780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
